rdca-dap: prototype 3: polycystic kidney disease modeling
Published 3 years ago • 72 plays • Length 13:56Download video MP4
Download video MP3
Similar videos
-
48:02
rdca-dap - value of integrated data and analytics in rare disease drug development
-
24:22
2022 rdca-dap workshop: case study 3, duchenne regulatory science consortia (d-rsc)
-
1:36:06
webinar: rdca-dap and eatris present rare disease drug development
-
58:49
webinar: how rdca-dap can help inform optimal trial design in progressive rare disease
-
12:03
rdca-dap drug development tool prototypes
-
57:04
rdca-dap: interpretation of novel biomarkers in related diseases through data interoperability
-
33:27
2021 pkd regulatory summit: translational strategies for adpkd
-
20:41
2022 rdca-dap workshop: case study 1, transplant therapeutics consortium (ttc)
-
4:11
c-path's polycystic kidney disease outcomes consortium executive director sorin fedeles
-
41:33
2022 rdca-dap workshop: new collaborations for rdca-dap
-
0:19
polycystic kidney disease: learn@visible body
-
38:32
rdca-dap launch live stream - am part 1
-
3:58
introduction to alexandre bétourné, rdca-dap
-
8:03
rdca-dap: how the data and analytics platform accelerates rare disease drug development
-
11:26
2022 rdca-dap workshop: case study 2, critical path for sickle cell disease consortium (cp-scd)
-
41:34
2021 pkd regulatory summit: arpkd: clinical course, trial endpoints, and imaging
-
35:05
2021 rdca-dap annual workshop: how rdca-dap is working to break down silos